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Abstract Amyotrophic lateral sclerosis (ALS) is a fatal
neurodegenerative disease. Mutations in Cu/Zn superoxide
dismutase (SOD1) are responsible for approximately 20 %
of the familial ALS cases. ALS-causing SOD1 mutants
display a gain-of-toxicity phenotype, but the nature of this
toxicity is still not fully understood. The Ras GTPase-activating protein-binding protein G3BP1 plays a critical role
in stress granule dynamics. Alterations in the dynamics of
stress granules have been reported in several other forms of
ALS unrelated to SOD1. To our surprise, the mutant G93A
SOD1 transgenic mice exhibited pathological cytoplasmic
inclusions that co-localized with G3BP1-positive granules in spinal cord motor neurons. The co-localization was
also observed in fibroblast cells derived from familial ALS

patient carrying SOD1 mutation L144F. Mutant SOD1,
unlike wild-type SOD1, interacted with G3BP1 in an RNAindependent manner. Moreover, the interaction is specific
for G3BP1 since mutant SOD1 showed little interaction
with four other RNA-binding proteins implicated in ALS.
The RNA-binding RRM domain of G3BP1 and two particular phenylalanine residues (F380 and F382) are critical
for this interaction. Mutant SOD1 delayed the formation
of G3BP1- and TIA1-positive stress granules in response
to hyperosmolar shock and arsenite treatment in N2A cells.
In summary, the aberrant mutant SOD1–G3BP1 interaction
affects stress granule dynamics, suggesting a potential link
between pathogenic SOD1 mutations and RNA metabolism
alterations in ALS.

J. Gal and L. Kuang contributed equally to this manuscript.
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Amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) is a progressive neurodegenerative disease with no
cure available [37, 49, 71]. A better understanding of the
molecular etiology of the disease is needed to develop
effective preventive measures or cures. Approximately
10–15 % of ALS cases are familial and studies of the ALS
genes whose mutations cause familial ALS have provided
valuable insights into the disease mechanism. The first
identified ALS gene encodes copper/zinc superoxide dismutase (SOD1) [14, 51]. The ALS mutations in SOD1
cause toxicity that is foreign to the wild-type (WT) protein (termed as “gain-of-function”) [9], but the nature of
such toxicity is still not fully understood. Mutations in a
group of genes involved in RNA metabolism have been

13

564

found in recent years, including TDP-43 [45], FUS [35,
67], ataxin-2 [19], hnRNPA1 [33] and Matrin-3 [29]. The
seemingly unrelated pathogenic mechanisms elicited by
the mutations in SOD1 and in RNA metabolism regulators
have not been reconciled yet.
The Ras GTPase-activating protein-binding protein
G3BP1 [48] is an important regulator of RNA metabolism [5, 24, 66], translation [1, 47] and stress granule (SG)
dynamics [2, 65, 70]. G3BP1 was reported to play a critical
role in the secondary aggregation step of SG formation [2],
and has been used as a reliable marker of SGs [31]. The
misregulation of SG dynamics has been reported in many
forms of ALS [36]. G3BP1 is critical for neuronal survival
since G3BP1 null mice demonstrate widespread neuronal
cell death in the central nervous system [73]. G3BP1 is
also critical for synaptic plasticity and calcium homeostasis
[43].
In this study, we initially tested whether aggregated
ALS mutant SOD1-containing inclusions were in any way
related to G3BP1-positive stress granules. Interestingly,
mutant SOD1 inclusions were co-localized with G3BP1positive granules in spinal cord motor neurons of G93A
SOD1 transgenic mice as well as in cultured cells. ALSrelated mutants of SOD1, unlike wild-type SOD1, interacted with G3BP1 and the interaction was preserved in
the presence of RNase, suggesting a direct protein–protein
interaction. Domain deletion mutations, molecular modeling and point mutagenesis showed that the RNA-binding
RRM domain of G3BP1 interacted with mutant SOD1
via residues critical to the RNA binding. Furthermore, the
expression of mutant SOD1 perturbed SG dynamics and
resulted in a delayed formation of SG in response to hyperosmolar stress and arsenite treatment. Our results suggest
that G3BP1 represents a potential link between pathogenic
SOD1 mutations and RNA metabolism alterations in ALS.
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mutation and the W32S SOD1 mutation were introduced
with the QuikChange II Site-Directed Mutagenesis Kit
(Agilent). The A4V/W32S double mutant SOD1-EGFP
and the EGFP-G3BP1 expression constructs were generated by subcloning the respective fragments to pEGFP-N3
and pEGFP-C3 (Clontech), respectively. The mCherry-WT
and F380L/F382L double mutant G3BP1 constructs were
made by subcloning the respective G3BP1 fragments to
pmCherry-C1 (Clontech). All plasmid constructs were verified with sequencing.
Cell culture and transfection
N2A and HEK293T (293T) cells were cultured in DMEM
(Sigma, D5796) supplemented with 10 % fetal bovine
serum and penicillin–streptomycin at 37 °C in 5 %
CO2/95 % air with humidification. N2A and 293T cells
were transfected with Lipofectamine 2000 (Life Technologies) and Polyethylenimine “Max” (Polysciences, Inc.),
respectively. The G3BP1-null 293T cells were generated
by employing CRISPR technology (G3BP1 Double Nickase Plasmids, Santa Cruz, sc-400745-NIC) following the
manufacturer’s protocol.
Animals
Transgenic mouse strains B6.Cg-Tg(SOD1)2Gur/J and
B6.Cg-Tg(SOD1-G93A)1Gur/J [26] were bred and maintained as hemizygotes at the University of Kentucky animal facility. Transgenic mice were identified using PCR.
The mice were killed at age 60, 90 and 125 ± 5 days.
Mice were anesthetized with an intraperitoneal injection
of 0.1 ml Pentobarbital (50 mg/ml, Abbott Laboratories)
and transcardially perfused with 0.1 M phosphate buffered
saline (PBS), pH 7.5 before spinal cords were dissected.
All animal procedures were approved by the university
IACUC committee.

Materials and methods
Clinical materials
Plasmids
The WT and A4V mutant SOD1-EGFP [74], SOD1-3xHA
[21], 3xFLAG-FUS [22], FLAG-TDP-43 (a gift from Dr.
Francisco Baralle) [3], FLAG-MATR3 (a gift from Dr.
Yossi Shiloh, Addgene plasmid # 32880) [52], and FLAGhnRNPA1 (a gift from Dr. J. Paul Taylor) [33] expression
constructs were previously reported. The human G3BP1
expression constructs used in this study were based on
the FLAG-G3BP1 plasmid [34], a generous gift from Dr.
Zhi-Min Yuan (University of Texas Health Science Center
at San Antonio). The 3xFLAG-tagged G3BP1 constructs
were generated from p3xFLAG-CMV10 (Sigma) using
standard cloning techniques. The F380L/F382L G3BP1
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Human skin fibroblast cell cultures were established as previously described [16]. Briefly, punch skin biopsy (3 mm)
was obtained after informed consent from a 63-year-old
male with symptomatic ALS with a documented L144F
SOD1 mutation (Athena Diagnostics). The control skin
biopsy was obtained from a 64-year-old healthy male who
was free of neurological disease or any known ALS gene
mutation. Skin biopsies were washed with PBS and cut into
small pieces. Fibroblast growth medium [MEM (Sigma,
M5650) supplemented with 20 % FBS, 2 mM l-glutamine, 100 unit/ml penicillin, and 100 µg/ml streptomycin] was added to the minced biopsy tissue and transferred
along with tissue fragments into tissue culture plates.

Acta Neuropathol (2016) 132:563–576

Cultures were maintained in a humidified atmosphere of
5 % CO2/95 % air at 37 °C to allow fibroblast cells grow
from tissue fragments. Fibroblast cells were then maintained under the same conditions as above. The study was
approved by the Institutional Review Board of the University of Kentucky.
Fluorescence microscopy
N2A or 293T cells were seeded on gelatin-treated glass
coverslips and transfected with SOD1-EGFP constructs.
Twenty-four hours later, cells were rinsed with 1× PBS,
fixed with 4 % formaldehyde in 1× PBS, and permeabilized with 1× PBS supplemented with 0.25 % TritonX100. Primary fibroblast cells were cultured, fixed and
permeabilized similarly as above. Mouse spinal cords were
dissected, post-fixed in 4 % formaldehyde in 1× PBS for
3 h, cryopreserved in 30 % sucrose overnight, embedded in
Tissue-Tek OCT compound (Sakura). Sections were cut at
12 μm and permeabilized with 1× PBS supplemented with
0.1 % Triton-X100. The primary antibodies were sheep
anti-human SOD1 (The Binding Site, PC077), mouse antiG3BP1 (BD Biosciences, 611126), rabbit anti-G3BP1
(Proteintech, 13057-2-AP), goat anti-TIA1 (Santa Cruz,
sc-1751), mouse anti-eIF3 p110 (Santa Cruz, sc-74507)
and mouse anti-GE-1/p70 S6 kinase alpha (Santa Cruz,
sc-8418). The secondary antibodies were Alexa Fluor 488
donkey anti-sheep (Life Technologies, A11015), Alexa
Fluor 568 donkey anti-mouse (Life Technologies, A10037),
Alexa Fluor 647 donkey anti-mouse (Life Technologies,
A-31571), Alexa Fluor 568 donkey anti-rabbit (Life Technologies, A-10042), Alexa Fluor 647 donkey anti-rabbit
(Life Technologies, A-31573), and Alexa Fluor 568 donkey anti-goat (Life Technologies, A-11057). The samples
were mounted by applying Vectashield Mounting Medium
(Vector Laboratories) and visualized using a Nikon A1 or a
Leica SP5 confocal microscope with a 60× objective.
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3xFLAG peptide (Sigma, F4799). Where indicated, RNase
Cocktail (Ambion Life Technologies, AM2286) was added
to the immunoprecipitation mixtures at 1:100 dilution.
The in vitro SOD1–G3BP1 binding assays were performed using 2 μg WT or G93A mutant human SOD1
purified from insect cells as described [27] and 1.5 μg of
6xHis-tagged human G3BP1 purified from E. coli (Fitzgerald Industries, 80R-1601) in 500 μl 1× RIPA buffer. The
mixtures were incubated at 37 °C for 2 h, cooled to 4 °C
and G3BP1 was immunoprecipitated with mouse antiG3BP1 (Millipore, 05-1938) and Protein G UltraLink
Resin (Thermo Scientific Pierce, 53126).
Western blotting
The nitrocellulose membranes were blocked and antibodies
were applied in 5 % milk in TBST (100 mM TRIS–HCl,
pH7.5, 0.9 % NaCl, 0.1 % Tween-20). The antibodies used
were rabbit anti-G3BP1 (Millipore, 07-1801), rabbit antiSOD1 (Santa Cruz, sc-11407), mouse anti-FLAG M2-HRP
(Sigma, A8592), rabbit anti-HA (Santa Cruz, sc-805),
mouse anti-PABP1 (Santa Cruz, sc-32318) and goat antiactin (Santa Cruz, sc-1616). All immunoblotting images
were acquired using a BioRad ChemiDoc MP system.
In silico docking
The homology model of the RRM domain of G3BP1 was
obtained using a leading homology modeling server Raptor
X [30]. The model was docked to the SOD1 A4V mutant
dimer (PDB ID: 3GZQ, [23]) using the protein–protein
interaction modeling server HADDOCK [17]. The docking model was further refined using Rosetta Docking [12]
as implemented in the ROSIE server [40], which evaluates
protein–protein complexes by using rigid body perturbations of the protein chains.
Stress granule induction and analysis

Co‑immunoprecipitation assays
The lysates were prepared in 1× RIPA buffer (Millipore)
supplemented with protease inhibitor cocktail (Sigma,
P-8340, 1:500) and 1 mM sodium orthovanadate. Mouse
spinal cord extracts were prepared using a dounce homogenizer. Transfected cell lysates were homogenized by passing through a 23-gauge needle several times. Immunoprecipitations were performed at 4 °C for 2 h. The endogenous
G3BP1 immunoprecipitations were done from spinal cord
extracts with rabbit anti-G3BP1 Antibody (Millipore,
07-1801) and Protein A UltraLink Resin (Thermo Scientific Pierce, 53139). The FLAG immunoprecipitations were
performed using EZview Red Anti-FLAG M2 Affinity Gel
(Sigma, F2426) and the bound proteins were eluted with

N2A cells grown on gelatin-treated glass coverslips were
transfected with WT or A4V mutant SOD1–EGFP constructs. Twenty-four hours later, the cells were treated
with 0.5 M d-sorbitol (Sigma, S1876) or 0.5 mM sodium
arsenite dissolved in fresh medium for the indicated times
at 37 °C to induce stress granules, with or without recovery in fresh medium as indicated. Control cells were treated
with fresh medium without sorbitol or arsenite. The cells
were fixed and G3BP1 immunofluorescence experiments
were performed as above. Z-stack images of random viewfields were acquired with identical imaging parameters.
Maximum intensity projections of the Z-stacks were analyzed for stress granule formation as published [10] using
ImageJ (http://imagej.nih.gov/ij). ANOVA with post hoc
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Tukey HSD (honest significant difference) test was used
to determine p values for multiple pair-wise comparisons.
Student’s t test (two-tailed distribution, two-sample unequal variance) was used to determine p values for simple
pair-wise comparison.

Results
Mutant SOD1 inclusions are co‑localized with stress
granule markers in ALS model systems
We set forth to determine whether there is a correlation
between G3BP1-positive stress granules and mutant SOD1
inclusions in murine and cellular ALS model systems.
Interestingly, we found that mutant SOD1 inclusions generally co-localized with G3BP1 in spinal cord motor neurons from 90-day-old symptomatic G93A mutant SOD1
transgenic mice (Fig. 1a). In contrast, no obvious G3BP1
or SOD1 inclusions were observed in age- and gendermatched WT SOD1 transgenic mice. The G93A SOD1
inclusions also co-localized with an additional stress granule marker, TIA1 [31] (Fig. 1a). The co-localization of all
three proteins, G93A SOD1, TIA1 and G3BP1 was also
demonstrated (Supplemental Fig. 1). No fluorescence signals were observed in primary antibody-omitted samples
(Supplemental Fig. 2). Examination of three pairs of WT
and G93A SOD1 mice showed that 49 % spinal cord motor
neurons in 90-day-old G93A mice contained SOD1 inclusions and nearly all motor neurons with SOD1 inclusions
also contained G3BP1 co-inclusions (Fig. 1b). In contrast,
less than 3 % motor neurons in WT SOD mice showed
SOD1 inclusions and no WT SOD1–G3BP1 co-inclusions
were observed.
In addition, the co-localization of G3BP1 with SOD1
inclusions was observed in human fibroblasts derived
from an ALS patient carrying the L144F SOD1 mutation
(Fig. 1c). The SOD1 inclusions were also co-localized with
TIA1 in L144F SOD1 ALS patient fibroblast cells (Fig. 1c,
Supplemental Fig. 3). In contrast, no SOD1 inclusions
were observed in fibroblast cells derived from an age- and
gender-matched control (Fig. 1c, Supplemental Fig. 3).
In N2A cells transfected with A4V mutant SOD1, the
G3BP1-positive mutant SOD1 inclusions were mostly
round shaped with approximately 1–3 μm diameter
(Fig. 1d). Quantification of 20 randomly selected viewfields from three independent experiments showed that
approximately 22 % of transfected cells contained mutant
SOD1 inclusions, and 97 % of N2A cells with mutant
SOD1 inclusions also showed G3BP1 co-inclusions
(Fig. 1d). Approximately 4 % of N2A cells expressing
WT SOD1 contained inclusions and no G3BP1 co-inclusions were observed. The mutant SOD1 inclusions also
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Fig. 1  G3BP1 co-localizes with ALS mutant SOD1 inclusions. a▸
Immunofluorescence of SOD1, G3BP1 and TIA1 in the spinal cord
of 90-day-old G93A and WT SOD1 transgenic mice. Top G3BP1 and
G93A mutant SOD1 are co-localized in inclusions in motor neurons
(illustrated by arrows) while WT SOD1 shows even cytoplasmic distribution. Bottom TIA1 and G93A mutant SOD1 are co-localized in
inclusions in motor neurons (illustrated by arrows). b Quantification
of G93A SOD1 inclusions and the co-localization of G93A SOD1
and G3BP1 in mouse spinal motor neurons. Three pairs of WT and
G93A mice were examined and a total of over 200 motor neurons
were counted. c Immunofluorescence of SOD1, G3BP1 and TIA1
in human fibroblasts harboring the L144F ALS mutation in SOD1
and in control fibroblasts. Top G3BP1 and SOD1 are co-localized in
inclusions in the L144F SOD1 ALS patient-derived cells (illustrated
by arrows), whereas WT SOD1 shows even cytoplasmic distribution
in the control cells. Bottom TIA1 and L144F mutant SOD1 are colocalized in inclusions as illustrated by the arrow. d Confocal microscopic images of G3BP1, TIA1 and SOD1 in N2A cells expressing A4V mutant (top) or WT (bottom) SOD1. A4V mutant SOD1,
G3BP1 and TIA1 are co-localized in inclusions with the size of
approximately 1–3 µm, whereas WT SOD1 shows even cytoplasmic
distribution. e Quantification of A4V SOD1 inclusions and the colocalization of A4V SOD1 and G3BP1 in N2A cells. Three independent experiments were performed and at least five random viewfields
from each experiment were included in the quantification. f Confocal microscopic images of A4V mutant SOD1 and the P-body marker
GE-1 in N2A (top) and 293T (bottom) cells. Mutant SOD1 inclusions
and P-bodies are illustrated by arrows and zoom-in images show
that they are localized in close proximity to each other. The confocal
microscopic images were acquired with a Nikon A1 microscope. The
nuclei were stained with DAPI. Scale bars 10 μm

co-localized with TIA1 (Fig. 1d) and another SG marker
eIF3 [31] (Supplemental Fig. 4) in N2A cells. Similar colocalization of mutant SOD1 inclusions and G3BP1 was
observed in transfected 293T cells (Supplemental Fig. 5).
Processing bodies (P-bodies) are discrete cytoplasmic
foci where mRNA degradation takes place [55] and are
often intimately juxtaposed to stress granules [32]. We
found that mutant SOD1 inclusions in N2A and 293T cells
did not stain positive for the P-bodies marker GE-1 [31,
57], but were in close proximity to GE-1 positive P-bodies instead (Fig. 1f). The results collectively suggest that
mutant SOD1 inclusions, which are positive for multiple
stress granule markers, are likely stress granules.
ALS mutants of SOD1 interact with G3BP1
G3BP1 immunoprecipitation was performed with spinal cord extracts from 60-, 90- and 125-day-old WT or
G93A mutant SOD1 transgenic mice. A small amount of
WT SOD1 was co-precipitated with G3BP1 while a significantly higher amount of G93A mutant SOD1 was coprecipitated with G3BP1 (Fig. 2a). We next tested whether
G3BP1 can interact with other ALS-related SOD1 mutants.
Cells were co-transfected with 3xHA-tagged WT or A4V,
G85R or G93A mutant SOD1 and FLAG-tagged G3BP1 or
FLAG vector control. FLAG immunoprecipitation showed

Acta Neuropathol (2016) 132:563–576

that A4V, G85R and G93A mutant SOD1 all co-precipitated with FLAG-G3BP1 (Fig. 2b, lanes 7–9) while no coprecipitation of WT SOD1 was detected (lane 6). As negative controls, no WT or mutant SOD1 was co-precipitated
with the FLAG vector (Fig. 2b, lanes 1–5).
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ALS mutant SOD1 directly interacts with G3BP1
Since G3BP1 is an RNA-binding protein, we tested
whether the mutant SOD1–G3BP1 interaction was dependent on RNA. RNase was either included or omitted in the
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Fig. 2  ALS mutants of SOD1 interact with G3BP1. a Endogenous
G3BP1 was immunoprecipitated from 60, 90 or 125-day-old WT or
G93A human SOD1 transgenic mouse spinal cord extracts. A significantly higher amount of G93A SOD1 was co-precipitated with
G3BP1 than WT SOD1 was. b FLAG-G3BP1 was immunoprecipitated from cellular extracts of 293T cells transfected with the indicated expression constructs. Multiple ALS-causing mutants were coprecipitated with G3BP1. c FLAG-G3BP1 was immunoprecipitated
from cellular extracts of 293T cells transfected with the indicated

immunoprecipitation mixture and the FLAG-G3BP1 coimmunoprecipitation experiment was subsequently performed. Mutant SOD1 was still co-precipitated by G3BP1
in the presence of RNase (Fig. 2c, lanes 5, 6). The poly
A-binding protein PABP1 was included as a control of the
RNase treatment since G3BP1 was reported to interact with
PABP1 in an RNA-dependent manner [44, 58]. The interaction of G3BP1 with the endogenous PABP1 was completely abolished in the presence of RNase (Fig. 2c, lanes
5, 6). These results support that the G3BP1–mutant SOD1
interaction was RNA-independent.
We next tested whether the G3BP1–mutant SOD1 interaction was direct. Purified WT or G93A mutant SOD1 and
purified G3BP1 were used for immunoprecipitation. G93A
SOD1, unlike WT SOD1, efficiently co-precipitated with
G3BP1 (Fig. 2d, lane 2 versus lane 4), showing that mutant
SOD1 and G3BP1 interact directly.

Acta Neuropathol (2016) 132:563–576

expression constructs, with or without the inclusion of RNase in the
immunoprecipitation, as indicated. d G3BP1 purified from E. coli
and WT or G93A mutant SOD1 purified from insect cells were combined in vitro, followed by G3BP1 immunoprecipitation. The immunoprecipitations were followed by western blotting with the indicated
antibodies. The positions and sizes of the closest molecular weight
marker bands are shown. IB immunoblot, IP immunoprecipitation,
Ext whole cell extracts (a–c) or pre-IP mixture (d)

Fig. 3  Mutant SOD1 selectively interacts with G3BP1. FLAGtagged G3BP1 (GBP), hnRNPA1 (hA1), FUS, TDP-43 (TDP) or
Matrin-3 (MAT) was co-transfected with HA-tagged WT or A4V
SOD1. FLAG immunoprecipitations were performed and followed by
western blotting with the indicated antibodies. A4V SOD1 was only
co-precipitated with G3BP1 but not other RNA-binding proteins. IB
immunoblot, IP immunoprecipitation, Ext whole cell extracts

The specificity of the mutant SOD1–G3BP1 interaction
We next tested whether mutant SOD1 interacts with other
RRM domain-containing RNA-binding proteins or specifically with G3BP1. The RNA-binding proteins implicated in
ALS, hnRNPA1, FUS, TDP-43 and Matrin-3 were examined. Cells were co-transfected with WT or A4V mutant
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SOD1 along with FLAG-tagged G3BP1, hnRNPA1, FUS,
TDP-43 or Matrin-3. FLAG immunoprecipitation was performed and A4V mutant SOD1 only co-precipitated with
G3BP1 (Fig. 3, lane 4), but not with any of the other four
FLAG-tagged RNA-binding proteins (hnRNPA1, FUS,
TDP-43 and Matrin-3).

Acta Neuropathol (2016) 132:563–576
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Fig. 4  The binding of mutant SOD1 is mediated by the RRM
domain of G3BP1. a The schematic domain structure of G3BP1. b
The RRM domain of G3BP1 is necessary for the binding of mutant
SOD1. A series of domain deletion mutants of G3BP1 were tested in
FLAG-G3BP1 immunoprecipitations. c The isolated RRM domain of
G3BP1 is sufficient for binding to mutant SOD1. FLAG immunoprecipitations were performed on cellular extracts with the expression
of indicated constructs. d In silico docking of A4V mutant SOD1

(green) and the RRM domain of G3BP1 (purple). The F380 and F382
residues of G3BP1 and W32 of SOD1 are shown in stick representation. e The F380 and F382 residues of G3BP1 and the W32 residue
of mutant SOD1 are important for the mutant SOD1–G3BP1 interaction. FLAG immunoprecipitations were performed followed by western blotting with the indicated antibodies. 2FL F380L/F382L double
G3BP1 mutant, 4V32S A4V/W32S double SOD1 mutant, IB immunoblot, IP immunoprecipitation, Ext whole cell extracts

Mutant SOD1 interacts with the RRM domain
of G3BP1 via residues critical to RNA binding

A4V SOD1 (Fig. 4c). Thus, the RRM domain of G3BP1 is
necessary and sufficient for mutant SOD1 binding.
The ALS-related mutants of SOD1 were reported to
display higher hydrophobicity than WT SOD1 [64]. We
hypothesized that a hydrophobic gain-of-interaction might
be responsible for the mutant SOD1–G3BP1 interaction.
In the lack of an experimentally determined structure of
G3BP1, a homology model of the RRM domain of G3BP1
was obtained with a p value 4.0 × 10−6 based on Bruno
protein RRM domain (PDB ID: 2KHC) as the template
using a leading homology modeling server Raptor X [30].
We next performed in silico docking of the G3BP1 RRM
homology model with the crystal structure of A4V mutant
SOD1 (PDB ID: 3GZQ, [23]) using the HADDOCK protein–protein interaction modeling server [17]. The docking model was further refined using the Rosetta Docking
algorithm [12] that evaluates protein–protein complexes
by using rigid body perturbations of the protein chains.

G3BP1 is a multi-domain protein consisting of an NTF2
oligomerization domain, a glutamic acid-rich domain, a
PxxP domain and an RNA-binding RRM domain [65]
(Fig. 4a). To determine which domain is responsible for
the binding of mutant SOD1, we generated G3BP1 domain
truncation mutants and tested their ability to co-precipitate
A4V SOD1. Removing the RRM domain abolished the
co-precipitation of A4V mutant SOD1 (Fig. 4b, lane 4),
whereas truncation of the NTF2 domain did not impair
A4V SOD1 binding (lane 5). In addition, the PxxP-RRM
domain fragment co-precipitated with A4V mutant SOD1
(lane 8), whereas the NTF2-Glu-rich domain fragment
(lane 6) or the Glu-rich domain–PxxP domain fragment
(lane 7) did not co-precipitate with mutant SOD1. Furthermore, the RRM domain alone also co-precipitated with
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The docking model with the minimal energy is shown in
Fig. 4d. The model positioned the RRM domain of G3BP1
above the crevice between two monomers of SOD1. Interestingly, the F380 and F382 residues of G3BP1 RRM and
the W32 residue of SOD1 are located in close proximity
(Fig. 4d), suggesting that these residues are critical to the
interaction.
We generated the F380L/F382L double mutation (2FL),
which caused a significant loss of interaction with mutant
SOD1 (Fig. 4e, lane 6 compared to lane 5). In addition, we
introduced a W32S mutation into A4V SOD1 and found
that the co-precipitation of the A4V/W32S mutant with
G3BP1 was impaired as compared to the A4V mutant
(lane 5 versus lane 7). The interaction between A4V/W32S
SOD1 and F380L/F382L G3BP1 was barely detectable
(lane 8) as compared to the interaction between A4V SOD1
and wild-type G3BP1 (lane 5). Therefore, the F380 and
F382 residues in the RRM domain of G3BP1 and the W32
residue of SOD1 directly participate in the mutant SOD1–
G3BP1 interaction.
The mutant SOD1–G3BP1 interaction is critical to the
co‑localized inclusions
We tested the significance of mutant SOD1–G3BP1 interaction in the formation of protein inclusions by mutating
the W32 residue in SOD1 and the F380 and F382 residues
in G3BP1. G3BP1-null 293T cells were transfected with
combinations of EGFP-tagged A4V or A4V/W32S double
mutant SOD1 and mCherry-tagged WT or F380L/F382L
double mutant G3BP1 (Fig. 5a). The number of transfected
cells with green, red and co-localized green/red inclusions
was counted from more than 150 cells in ten random viewfields. The percentage of co-localized green/red inclusions
out of the total number of green inclusions in the above
groups of cells is shown in Fig. 5b. Whereas A4V SOD1
co-localized with WT G3BP1 in 86.6 % of cells with SOD1
inclusions, the F380L/F382L G3BP1 mutation significantly decreased the co-localization to 36.1 % (p = 0.001),
and the W32S SOD1 mutation to 49.1 % (p = 0.001).
The combination of the W32S SOD1 mutation and the
F380L/F382L G3BP1 mutation resulted in only 14.7 %
of cells with SOD1 inclusions with co-localizing G3BP1
(p = 0.001) (Fig. 5b). The p value of comparing the single
protein mutation, i.e., F380L/F382L G3BP1 mutation or
W32S SOD1 mutation, to the combined mutations in both
proteins is also 0.001. The p values for the above pair-wise
comparisons were determined by ANOVA with post hoc
Tukey HSD test. The results suggest that, disruption of the
mutant SOD1–G3BP1 interaction by substituting the critical residues (W32 in SOD1 and F380 and F382 in G3BP1)
significantly reduced the double-positive inclusions.
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Fig. 5  The effect of W32 residue in SOD1 and F380 and F382 residues in G3BP1 on co-inclusions. a Confocal microscopic images
of G3BP1-null 293T cells transfected with combinations of EGFPtagged A4V or A4V/W32S SOD1 and mCherry-tagged WT or
F380L/F382L mutant G3BP1. B More than 150 cells in 10 random
view-fields were quantified as with green, red and green/red co-localized inclusions. The percentage of cells with green/red co-inclusions
versus the total number of cells with green inclusions was calculated.
The results of three independent parallel experiments are shown.
Mutations of W32, F380 and F382 residues in individual or both
proteins reduced the co-inclusions of mutant SOD1 and G3BP1. *p
values less than 0.01 as determined by ANOVA with post hoc Tukey
HSD test

Mutant SOD1 interferes with the dynamics of induced
G3BP1 stress granules
We hypothesized that the interaction of mutant SOD1
with G3BP1 could perturb the G3BP1-mediated stress
granule dynamics. We tested this hypothesis by examining the formation of induced G3BP1 stress granules in
N2A cells transfected with WT or A4V mutant SOD1
upon exposure to hyperosmolar stress (Fig. 6b) or arsenite treatment (Fig. 6c). The cells were treated with 0.5 M
sorbitol or 0.5 mM arsenite dissolved in fresh medium for
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Fig. 6  Mutant SOD1 expression interferes with the induction of G3BP1 stress granules
upon hyperosmolar stress or
arsenite treatment. Confocal
microscopic images of N2A
cells expressing EGFP-tagged
WT or A4V SOD1 (green)
without treatment (a), or 30 min
of sorbitol-induced hyperosmolar stress (b), or 30 min
of arsenite treatment (c). The
endogenous G3BP1 (purple)
and TIA1 (red) were stained
and images were acquired
with a Nikon A1 microscope.
The nuclei were stained with
DAPI. Scale bars 10 μm. d
Time course of the number of
G3BP1 granules upon sorbitolinduced hyperosmolar stress,
with or without recovery in
fresh medium. e Time course of
the number of G3BP1 granules
upon arsenite treatment, with
or without recovery in fresh
medium. f Quantification of
the number of G3BP1 granules
in N2A cells transfected with
EGFP vector or EGFP-tagged
WT or A4V SOD1. A half or a
quarter amount of A4V plasmid
was used to examine how A4V
mutant SOD1 levels influenced
the number of G3BP1-positive
granules. *p < 0.05 and
**p < 0.01 as determined by
ANOVA with post hoc Tukey
HSD test. The quantification
was based on four parallel
experiments, representing over
250 randomly selected cells for
each cell population
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30 or 60 min, or allowed to recover for 30 or 60 min in
fresh medium after 60 min of stress. Control cells were
subjected to the same procedure with medium not containing sorbitol or arsenite (Fig. 6a). The cellular distributions
of SOD1-EGFP, G3BP1 (purple) and an additional stress
granule marker TIA1 (red) were determined by immunofluorescence (Fig. 6a–c). It is noted that nearly all G3BP1
granules were also positive of TIA1.
The number of G3BP1 granules per cell was quantified from ten random view-fields for each cell population
at each time point. We found that after 30 min of hyperosmolar stress, the average number of G3BP1 granules was
significantly less in cells expressing A4V mutant SOD1 as
compared to cells expressing WT SOD1 (p = 0.005, Student’s t test) (Fig. 6d), suggesting a delayed formation of
stress granules in response to hyperosmolar stress. Similarly, the average number of G3BP1 granules was significantly less in cells expressing A4V mutant SOD1 as compared to cells expressing WT SOD1 (p = 0.01, Student’s t
test) (Fig. 6e) 30 min after arsenite treatment. The results
consistently suggest that mutant SOD1 delayed the formation of stress granules.
We further tested the effect of different levels of A4V
expression on the formation of G3BP1-positive stress granules (Fig. 6f). N2A cells were transfected with EGFP vector control or EGFP-tagged WT, A4V, or only half or quarter of A4V plasmids. The total amount of plasmids used in
all experiments was constant by including EGFP vector as
make-up. There was no statistically significant difference
in the number of G3BP1 granules in cells transfected with
the EGFP vector control or WT SOD1, suggesting that the
EGFP tag did not interfere with the experiment. Transfection of the full or half amount of A4V SOD1 resulted in
statistically significant reduction of the number of G3BP1
granules as compared to WT SOD1 transfection (p = 0.001
and 0.03, respectively, ANOVA with post hoc Tukey HSD
test), whereas transfecting only the quarter amount of
A4V SOD1 did not result in statistically different number of G3BP1 granules. Accordingly, our results support
the hypothesis that mutant SOD1 affects the dynamics of
G3BP1-positive stress granules, specifically delayed the
formation of stress granules.

Discussion
SOD1 was the first gene whose mutations were identified
to cause familial ALS [14, 51]. The cytoplasmic SOD1positive protein inclusions in affected motor neurons are a
hallmark of mutant SOD1-mediated ALS [50, 68]. In other
ALS cases, the pathological inclusions are often immunepositive of the RNA-binding protein TDP-43 [41, 60]. In
recent years, alterations in the dynamics of stress granules
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have emerged as a common theme in a wide range of ALS
cases [18, 36, 72]. ALS-related mutations in a range of
genes including TDP-43, FUS, hnRNPA1, profilin-1, angiogenin and C9ORF72 were found to result in abnormalities in stress granule dynamics [2, 4, 7, 13, 20, 22, 33, 38,
59, 61, 63, 69]. Ataxin-2, an ALS risk factor with polyglutamine expansions, can also regulate stress granules [19,
46]. These observations suggest that mutant SOD1-mediated ALS might represent an outlier in the ALS disease
mechanism. At the same time, the nature of the gain-oftoxicity caused by mutant SOD1 [9] is still not fully understood. This study was initiated to determine whether mutant
SOD1 also causes perturbed stress granule dynamics.
We have demonstrated here that cytoplasmic inclusions
of mutant SOD1 were immune-positive for two reliable
stress granule markers G3BP1 [31, 32] and TIA1 in the
G93A mutant SOD1 transgenic mouse spinal cord (Fig. 1a,
Supplemental Fig. 1), fibroblast cells derived from human
ALS patient (Fig. 1c, Supplemental Fig. 3), and cultured
cells (Fig. 1d, Supplemental Figs. 4, 5). A third stress granule marker eIF3 was also co-localized with mutant SOD1
and G3BP1 in cultured N2A cells (Supplemental Fig. 4).
Moreover, the G3BP1-positive mutant SOD1 inclusions
were found closely juxtaposed to P-bodies (Fig. 1f), supporting that they constitute stress granules [32]. It was previously reported that RNA stabilizer Hu Antigen R (HuR)
and TIA1-related protein (TIAR) were found along with
mutant SOD1 in detergent-insoluble aggregates [39]. However, that study did not test whether mutant SOD1 was
co-localized in stress granules. Our results provide the evidence that mutant SOD1 is co-localized with stress granules and consequently can potentially influence the dynamics of stress granules.
We found that the molecular basis for the co-localization
of mutant SOD1 inclusions and G3BP1 is that multiple
mutants of SOD1, but not WT SOD1, interact with G3BP1
(Fig. 2). This interaction was independent of RNA (Fig. 2c)
and was reconstituted with purified mutant SOD1 and
G3BP1 proteins (Fig. 2d), showing that mutant SOD1 and
G3BP1 directly interact with each other. In the previous
study showing the presence of HuR and TIAR in mutant
SOD1 aggregates, the amount of HuR and TIAR was significantly reduced by RNase treatment [39], suggesting
an indirect interaction between mutant SOD1 and HuR/
TIAR. This is in contrast to the RNA-independent direct
interaction between mutant SOD1 and G3BP1 found in this
study. Moreover, the interaction appeared to be specific for
G3BP1, while four other RNA-binding proteins implicated
in ALS, hnRNPA1, FUS, TDP-43 or Matrin-3 did not interact with mutant SOD1 (Fig. 3).
We further demonstrated that the RRM domain of
G3BP1 is essential and sufficient for the interaction with
mutant SOD1 (Fig. 4b, c). Molecular modeling and in silico
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docking results suggest that the F380 and F382 residues of
G3BP1 and the W32 residue of mutant SOD1 play a role in
this interaction (Fig. 4d). Site-directed mutagenesis results
showed that mutating F380 and F382 in G3BP1 and W32
in SOD1 indeed impaired the interaction (Fig. 4e). The
W32 residue of human SOD1 resides in the middle of the
third β-strand [25] and is exposed on the protein surface,
thus it is reasonable that it is involved in the interaction
with G3BP1. It has been reported that W32 potentiated the
aggregation and cytotoxicity of ALS mutant SOD1 [62]. In
addition, other ALS-related mutants of SOD1 were reported
to display aberrantly increased hydrophobicity [64], which
can enable the interaction with G3BP1. Consistent with
the interaction results, the W32S SOD1 mutation and the
F380L/F382L G3BP1 mutation significantly impaired the
co-localization of A4V SOD1 with G3BP1 (Fig. 5).
We found that expression of mutant SOD1 delayed the
formation of G3BP1 stress granules in response to hyperosmolar stress and arsenite treatment (Fig. 6). Hyperosmolar stress was chosen in our study since it was shown to
induce FUS [53] and TDP-43 [15] stress granules. Arsenite treatment is widely used to induce stress granules as it
induced oxidative stress [56]. There are multiple potential
mechanisms how the ALS mutant SOD1–G3BP1 interaction could perturb stress granule dynamics. The F380 and
F382 residues are well conserved in the “3” and “5” positions of the RNP1 motif (Supplemental Fig. 6A), which
are critical to RNA binding [42]. Substitution of conserved
phenylalanine residues in the RNP1 motif were reported
to impair RNA binding [8, 11, 54]. It is noted that F380L/
F382L mutation significantly reduced the interaction
between G3BP1 and PABP1 (Fig. 4e, lanes 6 and 8). Similarly, the G3BP1-PABP1 interaction was abolished in the
presence of RNase (Fig. 2c, lane 6), suggesting that F380L/
F382L mutation impaired the RNA binding of G3BP1.
Furthermore, we performed the RNA immunoprecipitation
experiment to measure the amount of c-myc RNA (one of
the few known RNA-binding partners of G3BP1 [66]) coprecipitated with G3BP1. The F380L/F382L double mutant
G3BP1 co-precipitated significantly less endogenous
c-myc mRNA than WT G3BP1 (p = 2.7 × 10−4), confirming that the F380 and F382 residues are important for
G3BP1 RNA binding (Supplemental Fig. 6b). As discussed
earlier, the interaction between mutant SOD1 and G3BP1
is not mediated by RNA, but rather direct protein–protein
interaction (Figs. 2, 4). It is conceivable that, when F380
and F382 are engaged in the interaction with mutant SOD1,
the RNA-binding ability of G3BP1 is impaired (a “competitive binding” model). Since G3BP1 plays a critical role in
stress granule dynamics [2, 65, 70], its impaired RNA binding can result in the delayed formation of stress granules.
An alternative mechanism is that mutant SOD1 can
sequester G3BP1 into inclusions, thus interfering with the
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G3BP1-mediated stress granule formation and dynamics. It
is interesting to note “rimming” of mutant SOD1 inclusions
by G3BP1 in cultured cells (Supplemental Fig. 5). Rimming of pathological aggregate structures was reported in
other neurodegenerative diseases, e.g., the rimming of huntingtin aggregates by p62 [6] or HDAC6 [28]. This observation suggests that G3BP1 could be secondarily sequestered
to mutant SOD1 inclusions, thus contributing to impaired
stress granule dynamics (a “sequestration” model). Future
studies are needed to distinguish these two potential mechanisms. It is also noted that G3BP1-positive granules were
relatively small in cells under hyperosmolar stress (Fig. 6b)
and large in cells treated with arsenite (Fig. 6c). In addition to the number of granules in this study, future studies
using live cell imaging techniques will examine sizes of
individual granules and determine whether multiple smaller
granules merge into large granules under different stress
conditions.
A delayed formation of stress granules in the presence
of mutant SOD1 (Fig. 6) are reminiscent of the reports
that the expression of ALS mutants of TDP-43 and FUS
also resulted in altered stress granules [4, 15, 38]. These
findings suggest that the misregulation of stress granule
dynamics represents a common pathophysiological feature
shared by ALS cases mediated by mutant SOD1 and those
caused by mutations in proteins involved in RNA metabolism. Perturbation of the physiological function of G3BP1
is especially harmful to neurons since G3BP1 is a neuronal
survival factor [43, 73]. The full complement of RNAs regulated by G3BP1 and in general by stress granules in the
central nervous system is unknown. In addition, it remains
unclear whether RNA molecules reside in the mutant SOD1
and G3BP1 positive co-inclusions or what functional role
RNAs play in the inclusions. Future studies will determine
the range of RNAs whose stability and function is affected
by altered stress granule dynamics in ALS.
Taken together, our results suggest that the aberrant
interaction of ALS-related SOD1 mutants with G3BP1 and
the resulting perturbation of stress granule dynamics are
likely important components of the toxicity of SOD1 mutations. In addition, a number of stress conditions are known
to induce G3BP1-positive stress granules that might in turn
seed mutant SOD1 inclusions. This two-hit scenario might
enhance the pathological aggregation of mutant SOD1. Our
findings reconcile the seemingly disparate disease mechanisms caused by mutations in SOD1 and several other
genes involved in RNA metabolism.
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